gvtcx

Clinical recombinant biological products or suitable recombinant biologicals

Medicines and Healthcare Products Regulatory Agency Published 10 Jul 2018 Contracts Finder

key details

Statusplanned
Category (CPV) 24000000 +4 more
Contract start17 Aug 2018
Contract end12 Aug 2021
Procedureopen
SME suitableNo
OCIDocds-b5fd17-a4a44296-94a4-478c-b4bb-9df29a37fb7f

description

The agency (MHRA) is looking for suppliers/distributors able to provide Clinical recombinant biological products or suitable recombinant biological used for CMC activities (Chemistry, Manufacturing, and Control) for the following biotherapeutic innovator monoclonal antibody and/or biosimilar. This requirement is mainly for RESEARCH USE ONLY and NOT for Whole Sale but NOT limited to this usage. It may be also used to develop reference materials and/or standards for distribution. We are looking for 1 to 5 batches of XXXX.

Terms & Conditions of Purchase for Goods can be downloaded from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency/about/procurement
Any queries related to our standard T&C please contact us.

Additional information: Further information and documents related to this tender will be published via our Bravosolution e-procurement portal in the near future. Meanwhile can you please register as a supplier on our e-procurement portal (Bravo solutions) if you haven't done already, it wouldn't take more than 5 to 10 minutes to register. To register, please follow the below mentioned web link:

https://mhra.bravosolution.co.uk/web_mhra/login.html

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 Jul 2018 Planning (planning) · d2b118ed-d44a-4b3b-8c37-19d45662df29-227722

more from Medicines and Healthcare Products Regulatory Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.